Key Takeaways JBL shares gained 92.9% in a year, while its forward P/E of 18.94 remains below the industry average.Manufacturing expansion in the U.S. and strategic buyout strengthen JBL as a key player in data center market.JBL projects $7.1B in fiscal 2025 from cloud and data center infrastructure market, up 54% year over year.Jabil, Inc. (JBL) is steadily expanding its portfolio offering to capitalize on the expanding cloud and AI data-center infrastructure market. The AI data-center infrastructure marke ...

Core Insights - Plexus Corp. reported third-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.90, an increase from $1.45 in the same quarter last year, surpassing the Zacks Consensus Estimate of $1.71 per share [1][7] - Revenues reached $1.018 billion, a nearly 6% year-over-year increase, but slightly missed the Zacks Consensus Estimate of $1.021 billion [2][7] Revenue Breakdown - Revenues from the Americas increased by 2%, while EMEA sales declined by 14.6%. Asia-Pacific revenues surged by 14% to $594 million [2] - The Industrial sector's revenues rose by 3% year over year to $415 million, contributing 41% to total revenues. The Healthcare/Life Sciences sector saw a 10.5% increase to $420 million, also contributing 41% [4][5] - Aerospace/Defense revenues inched up by 2.8% year over year to $183 million, contributing 18% to total revenues [8] Operational Highlights - Plexus secured 41 new manufacturing program wins, expected to generate $250 million in annualized revenues once fully ramped into production [3][7] - Gross profit on a GAAP basis increased by 9.4% year over year to $103.3 million, with a gross margin of 10.1% [10] Cash Flow and Balance Sheet - As of June 28, 2025, Plexus had cash and cash equivalents of $237.6 million, down from $310.5 million as of March 29 [11] - The company reported cash flows from operations of $26.9 million and free cash flow of $13.2 million for the quarter [11] Share Repurchase Program - Plexus repurchased $18.4 million worth of shares at an average price of $128.70 per share and added another $100 million to its existing buyback authorization [12] Q4 Outlook - For the fourth quarter of fiscal 2025, Plexus anticipates revenues between $1.025 billion and $1.065 billion, with non-GAAP EPS expected in the range of $1.82 to $1.97 [13]

Core Viewpoint - Plexus Corp reported strong adjusted earnings per share (EPS) for the second quarter of fiscal 2025, exceeding expectations, but revenues slightly missed estimates due to mixed performance across sectors [1][2]. Financial Performance - Adjusted EPS for Q2 fiscal 2025 was $1.66, up from $1.19 in the same quarter last year, surpassing the Zacks Consensus Estimate of $1.54 [1]. - Revenues reached $980.2 million, a 1.4% year-over-year increase, but fell short of the Zacks Consensus Estimate of $980.5 million [2]. - Gross profit on a GAAP basis increased 11% year over year to $97.8 million, with a gross margin of 10%, up from 9.1% [6]. Revenue Breakdown - Healthcare/Life Sciences revenues rose 8.4% year over year to $411 million, contributing 42% to total revenues [5]. - Industrial sector revenues decreased 5% year over year to $397 million, accounting for 40% of total revenues [4]. - Revenues from Asia-Pacific increased by 12.5% to $587 million, while EMEA sales declined by 32% [2]. Operational Highlights - Plexus secured 42 manufacturing program wins in the quarter, expected to generate $205 million in annualized revenues once fully ramped [3]. - Selling and administrative expenses rose 3% year over year to $49 million, while adjusted operating margin expanded by 80 basis points to 5.7% [8]. Balance Sheet and Cash Flow - As of March 29, 2025, cash and cash equivalents were $310.5 million, down from $317.2 million as of December 28, 2024 [9]. - Free cash flow for the quarter was reported at $16.5 million [9]. Share Repurchase and Future Outlook - The company repurchased $12.2 million of shares at an average price of $141.18, with $25 million remaining under its $50 million buyback authorization [10]. - For Q3 fiscal 2025, revenues are anticipated to be between $1 billion and $1.04 billion, with non-GAAP EPS expected in the range of $1.65-$1.80 [11].